Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thorsten Derlin

Showing results (101-110 of 192) with videos related to

Pageof 20
Sort By:
Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.
The Prostate|May 6, 2023
PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapyThorsten Derlin, Sabine Riethdorf, Udo Schumacher, et al.
The Prostate|March 19, 2020
Influence of short-term dexamethasone on the efficacy of <sup>177</sup> Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerThorsten Derlin, Jan M Sommerlath Sohns, Sebastian Schmuck, et al.
Theranostics|August 2, 2021
Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarctionRudolf A Werner, Annika Hess, Tobias Koenig, et al.
Atherosclerosis|March 11, 2017
Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on <sup>18</sup>F-fluorodeoxyglucose positron emission tomographyDiana Ernst, Desiree Weiberg, Niklas T Baerlecken, et al.
Cancers|April 3, 2021
Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine TumorsThorsten Derlin, Natalia Bogdanova, Fiona Ohlendorf, et al.
European Radiology|June 27, 2014
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancerIvayla Apostolova, Ingo G Steffen, Florian Wedel, et al.
Anticancer Research|March 19, 2017
<sup>68</sup>Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic TherapyChristoph Henkenberens, Christoph A VON Klot, Tobias L Ross, et al.
European Radiology|July 31, 2012
Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantationThorsten Derlin, Kersten Peldschus, Silvia Münster, et al.
European Radiology|October 8, 2013
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-offJohannes Salamon, Simon Veldhoen, Ivayla Apostolova, et al.
Pageof 20

Showing results (101-110 of 192) with videos related to

Sort By:
Pageof 20
Journal of Clinical Medicine|July 24, 2019
Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CTRudolf A Werner, James T Thackeray, Martin G Pomper, et al.
The Prostate|May 6, 2023
PSMA-heterogeneity in metastatic castration-resistant prostate cancer: Circulating tumor cells, metastatic tumor burden, and response to targeted radioligand therapyThorsten Derlin, Sabine Riethdorf, Udo Schumacher, et al.
The Prostate|March 19, 2020
Influence of short-term dexamethasone on the efficacy of <sup>177</sup> Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerThorsten Derlin, Jan M Sommerlath Sohns, Sebastian Schmuck, et al.
Theranostics|August 2, 2021
Molecular imaging of inflammation crosstalk along the cardio-renal axis following acute myocardial infarctionRudolf A Werner, Annika Hess, Tobias Koenig, et al.
Atherosclerosis|March 11, 2017
Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on <sup>18</sup>F-fluorodeoxyglucose positron emission tomographyDiana Ernst, Desiree Weiberg, Niklas T Baerlecken, et al.
Cancers|April 3, 2021
Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine TumorsThorsten Derlin, Natalia Bogdanova, Fiona Ohlendorf, et al.
European Radiology|June 27, 2014
Asphericity of pretherapeutic tumour FDG uptake provides independent prognostic value in head-and-neck cancerIvayla Apostolova, Ingo G Steffen, Florian Wedel, et al.
Anticancer Research|March 19, 2017
<sup>68</sup>Ga-PSMA Ligand PET/CT-based Radiotherapy for Lymph Node Relapse of Prostate Cancer After Primary Therapy Delays Initiation of Systemic TherapyChristoph Henkenberens, Christoph A VON Klot, Tobias L Ross, et al.
European Radiology|July 31, 2012
Comparative diagnostic performance of ¹⁸F-FDG PET/CT versus whole-body MRI for determination of remission status in multiple myeloma after stem cell transplantationThorsten Derlin, Kersten Peldschus, Silvia Münster, et al.
European Radiology|October 8, 2013
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-offJohannes Salamon, Simon Veldhoen, Ivayla Apostolova, et al.
Pageof 20